{
    "title": "Stinging Nettle vs HIV/AIDS",
    "inventor_name": "Mohammed Farhadi",
    "publication_year": 2012,
    "device_name": "IMOD (Setarud) herbal immunomodulator",
    "goal": "Boost the immune system of HIV/AIDS patients and improve clinical markers such as CD4 count.",
    "problem_addressed": "Human Immunodeficiency Virus (HIV) infection and acquired immunodeficiency syndrome (AIDS).",
    "concept_summary": "A herbal extract (IMOD) composed of Tanacetum vulgare (tansy), Rosa canina (rosehip), Urtica dioica (nettle) together with selenium, flavonoids and carotenes. The extract may be exposed to a pulsed high-frequency electromagnetic field before formulation. It is claimed to act as an immunomodulator, raising CD4 counts, improving lipid and liver profiles, and having antioxidant and anti-inflammatory effects when used alongside standard anti-retroviral therapy.",
    "detailed_description": "The invention describes a method for preparing a herbal extract: (a) providing plant material from Rosa sp., Urtica dioica and/or Tanacetum vulgare; (b) drying the material (20-50  deg C, 3-4 days); (c) extracting with ethanol (60-96 % v/v, preferably ~96 %); (d) incubating 20-40 days at 20-50  deg C; (e) obtaining the extract; (f) optionally adding selenium (1-100 mg/L, preferably 5-50 mg/L) and/or urea; (g) exposing the extract to a pulsed electromagnetic field (5-750 kHz, 10-200 W, 100-150 uT, 2-5 min, repeated three times). The final composition can be formulated for oral administration (solution, syrup, tablet, etc.) and is intended as an adjunct to HAART. Clinical observations report a significant rise in CD4 counts and modest improvements in lipid and liver parameters with minimal side effects.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Immunomodulation",
        "Antioxidant activity",
        "Anti-inflammatory effect",
        "Pulsed electromagnetic field exposure"
    ],
    "scientific_domains": [
        "Immunology",
        "Pharmacology",
        "Botany",
        "Biochemistry",
        "Electromagnetics"
    ],
    "mechanisms_of_action": [
        "Enhancement of CD4+ T-cell count",
        "Modulation of dendritic cell maturation",
        "Reduction of oxidative stress",
        "Synergistic effect of herbal phytochemicals with EM field"
    ],
    "materials": [
        "Tanacetum vulgare (tansy)",
        "Rosa canina (rosehip)",
        "Urtica dioica (nettle)",
        "Selenium",
        "Flavonoids",
        "Carotenes",
        "Ethanol (organic solvent)",
        "Urea (optional)"
    ],
    "energy_sources": [
        "Pulsed high-frequency electromagnetic field"
    ],
    "inputs": [
        "Plant material (leaves, stems, fruit)",
        "Ethanol solvent",
        "Selenium salt",
        "Urea (optional)",
        "Electromagnetic field parameters"
    ],
    "outputs": [
        "Herbal extract (IMOD)",
        "Pharmaceutical composition ready for oral or injectable use"
    ],
    "claimed_performance": "Significant increase in CD4 count in treated HIV patients; improvement in lipid profile and liver metabolism; minor side-effects reported.",
    "experimental_evidence": "Clinical trial phases involving 200 patients reported a rise in CD4 count; a review article (2012) summarizes safety and efficacy data.",
    "replication_status": "Tested on 200 patients (as reported by IRNA).",
    "keywords": [
        "HIV",
        "AIDS",
        "IMOD",
        "Setarud",
        "Herbal immunomodulator",
        "Urtica dioica",
        "Rosa canina",
        "Tanacetum vulgare",
        "Selenium",
        "Pulsed electromagnetic field"
    ],
    "related_technologies": [
        "Highly active antiretroviral therapy (HAART)",
        "Other herbal immunomodulators"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.85,
    "practicability_score": 0.7,
    "fringe_score": 0.4,
    "evidence_strength": 0.6,
    "risk_score": 0.2,
    "trl_estimate": 5,
    "source_urls": [
        "http://www.silentcures.com/The-AIDS-Cure.html",
        "https://www.youtube.com/watch?v=sdqx1m1oS1k",
        "http://www.ncbi.nlm.nih.gov/pubmed/22353002"
    ],
    "organizations": [
        "Iranian Ministry of Health",
        "IRNA (Islamic Republic News Agency)",
        "Silent Cures (website host)"
    ],
    "applications": [
        "Adjunct therapy for HIV/AIDS patients",
        "Immune system support",
        "Potential use in other immune-deficient conditions"
    ],
    "limitations": [
        "Not a cure; only adjunct to existing antiretroviral drugs",
        "Limited clinical data (small patient cohort, no large-scale randomized trials)",
        "Mechanistic role of the pulsed electromagnetic field not fully elucidated"
    ],
    "open_questions": [
        "What is the precise contribution of the electromagnetic field to therapeutic effect?",
        "How does IMOD compare directly with standard HAART in randomized controlled trials?",
        "Long-term safety of repeated EM-field exposure and selenium supplementation",
        "Optimal dosing regimen and formulation for maximal efficacy"
    ],
    "red_flags": [
        "Claims of significant CD4 increase based on limited, non-peer-reviewed data",
        "Potential over-reliance on a proprietary EM-field process without clear scientific validation",
        "Lack of independent replication outside the inventors' group"
    ],
    "evidence_quotes": [
        "A significant rise of CD4 count was observed in HIV patients treated by IMODacent in clinical trial phases.",
        "The drug, made after five years of research, has been tested on 200 patients, IRNA said.",
        "IMOD is a safe, naturally-derived immunomodulator that was introduced for treatment of HIV patients in Iran."
    ]
}